TAG's 2023 Pipeline Report: TB Treatment

Treatment Action Group launches the 2023 Tuberculosis Treatment Pipeline Report.

Read More →

TB preventive treatment community materials

Educational materials designed for community-based and civil society organizations to use to advocate for and teach people about TB preventive treatment.

Read More →

Community consensus on the earlier inclusion of pregnant women and persons in TB research

A consensus statement provides a framework for ensuring that pregnant and breastfeeding women and persons are better served by TB research and can fully benefit from scientific advancements in the prevention and treatment of TB.

Read More →

World TB Day 2024 campaign toolkit

The Stop TB Partnership releases the campaign toolkit for this year’s 'Yes! We Can End TB' World TB Day campaign on 24 March 2024.

Read More →

TB advocacy resource: A Different Kind of Gap

ACTON releases an advocacy tool exploring what funding gaps in the Global Fund’s Grant Cycle 7 mean for the fight against TB and what happens if they are not filled.

Read More →

WHO Rapid Communication: TB preventive treatment

The World Health Organization announces forthcoming updates on TB preventive treatment.

Read More →

The rejection of the bedaquiline patent opposition in Indonesia raises the risk of difficulty in accessing optimal TB therapy

The patent opposition was submitted by the Indonesia AIDS Coalition and Indonesia for Global Justice in November 2022 and was rejected by a decision from the Judiciary Panel on 9 November 2023.

Read More →

Identifying common opportunistic infections among people with advanced HIV disease

WHO releases a policy brief summarizing key WHO guidance on identifying the primary opportunistic infections among people with advanced HIV disease, including TB.

Read More →

Lindsay McKenna: What does it mean to be a good activist?

At the 2023 Union Conference, TAG's Lindsay McKenna sat down with Denis Godlevsky of ITPC EECA for a wide-ranging discussion on TB research, activism, and TAG's historic + present role shaping both.

Read More →

Survey: Provider attitudes to, and interest in, long-acting formulations of TB treatment

Healthcare providers and policymakers in LMICs are invited to take part in an online survey assessing their perspectives on long-acting TB preventive treatment.

Read More →

Page 4 of 133 · Total posts: 10

←First 3 4 5 Last→